Wockhardt Ltd has developed Nafithromycin, the first domestically produced antibiotic targeting multi-drug-resistant bacteria. This antibiotic is aimed at treating community-acquired bacterial pneumonia (CABP) in adults, the launch was...
November 28, 2024
